Trial intelligence / Profile preview

Leflunomide and Topical Corticosteroids for Bullous Pemphigoid

NCT00802243Phase 2Unknown

Sponsor
CHU de Limoges
Start
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of leflunomide in Bullous Pemphigoid (BP), sponsored by CHU de Limoges. Status: unknown.

02

Drugs

leflunomide
03

Conditions

Bullous Pemphigoid (BP)

Beyond the preview

Go deeper on NCT00802243.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00802243.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call